Samuel Whiting
CIK: 0001870373
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
TPST
Tempest Therapeutics, Inc.
Officer
Discretionary Trading P&L
Holdings
About Whiting Samuel
Whiting Samuel (SEC CIK 0001870373) files insider reports with the SEC as Chief Medical Officer of Tempest Therapeutics, Inc. (TPST).
Signal8 holds 1 ownership filing by Whiting Samuel, a Form 4, filed on Jan 6, 2025. Those filings report 1 transaction, the latest on Jan 2, 2025. Signal8's Form 4 history starts in Sep 2024.
The business address on Whiting Samuel's filings is in BRISBANE, CA.
Recent filings by Whiting Samuel
- Jan 2, 2025: Grant or award of TPST derivative securities (Form 4, code A).
Other insiders filing for Tempest Therapeutics, Inc. (TPST)
- Frederick John W., Director
- Smith Nancy Freda, Director
- Angel Matthew, CEO and President
- Yee John D., Director
- Richey William Drake, Director
- Trojanowski Justin, Corporate Controller